期刊文献+

TSP-1、TGF-β和PPAR-γ在脑胶质瘤中的表达及其与微血管密度的关系 被引量:3

Expression of TSP-1,TGF-βand PPAR-γin glioma and relationships with microvascular density
原文传递
导出
摘要 目的探讨凝血酶敏感蛋白-1(TSP-1)、生长转化因子-β(TGF-β)和过氧化物酶体增殖物激活受体-γ(PPAR-γ)在脑胶质瘤中的表达及其与血管生成的关系。方法应用免疫组织化学法对62例胶质瘤组织中的TSP-1、TGF-β和PPAR-γ的表达及微血管密度(MVD)进行检测。结果 TSP-1、TGF-β和PPAR-γ在低级别胶质瘤中的阳性率分别为78.1%、43.7%和93.7%;在高级别胶质瘤中的阳性率分别为46.7%、93.3%和40.0%,PPAR-γ、TSP-1与TGF-β的表达均呈负相关(P<0.05)。低级别组MVD为26±5.2,高级别组MVD为41±7.3,二者之间的差异有统计学意义(P<0.05)。TSP-1、PPAR-γ与MVD呈负相关(P<0.05),TGF-β与MVD呈正相关(P<0.05))。结论 TSP-1、TGF-β、PPAR-γ与脑胶质瘤组织的MVD密切相关,可能参与了脑胶质瘤血管生成的调控。 Objective To explore expressions of thrombospondin-1 (TSP-1), transforming growth factor-β(TGF-β), and peroxisome proliferator activated receptor-y(PPAR-y) in glioma tissues and its correlations with tumor angiogenesis. Methods Expressions of TSP-1, TGF-β and PPAR-y and microvascular density (MVD) in 62 glioma cases of low and high grades were examined with SABC immunohistochemistry. Results The expression rates of TSP-1, TGF- β and PPAR-y in low-grade gliomas were 78.1%, 43.7% and 93.7% respectively, and expression rates in high-grade gliomas were 46.7%, 93.3% and 40.0% respectively, and expression of TSP-1 and PPAR-yboth had negative correlations with TGF-β(P 〈0.05). It was found that the MVD of low-grade gliomas(26 ±5.2) was significantly lower than that of high-grade gliomas( 4l ± 7.3 ) (P 〈 0.05 ). TSP-1 and PPAR-yhad negative correlations with MVD( P 〈 0.05 ), and TGF-β had a positive correlation with MVD ( P 〈 0.05 ). Conclusion The expression levels of TSP-1, TGF-β and PPAR-y are correlated with wlioma MVD and these factors may be involved in glioma angiogenesis.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第2期53-56,共4页 Journal of Shandong University:Health Sciences
基金 山东省科技发展计划项目(2010GSF10225) 山东省自然科学基金资助项目(Y2008C64) 山东省科技厅青年博士基金资助项目(2007BSB02028)
关键词 凝血酶敏感蛋白-1 生长转化因子-β 过氧化物酶体增殖物激活受体-Γ 微血管密度 胶质瘤 Thrombospondin-1 Transforming Growth Factor-β Peroxisome Proliferator Activated Receptor-',/ Microvascular density Glioma
  • 相关文献

参考文献2

二级参考文献40

  • 1任祖渊.侵袭性垂体瘤的研究现状及展望[J].中华神经外科杂志,2000,16:112-115.
  • 2[1]Lai WK,Adams DH.Angiogenesis and chronic inflammation;the potential for novel therapeutic approaches in chronic liver disease.J Hepatol 2005; 42:7-11
  • 3[2]Medina J,Arroyo AG,Sanchez-Madrid F,Moreno-Otero R.Angiogenesis in chronic inflammatory liver disease.Hepatology 2004; 39:1185-1195
  • 4[3]Drixler TA,Vogten MJ,Ritchie ED,van Vroonhoven TJ,Gebbink MF,Voest EE,Borel Rinkes IH.Liver regeneration is an angiogenesis-associated phenomenon.Ann Surg 2002; 236:703-711; discussion 711-712
  • 5[4]Corpechot C,Barbu V,Wendum D,Kinnman N,Rey C,Poupon R,Housset C,Rosmorduc O.Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.Hepato/ogy 2002; 35:1010-1021
  • 6[5]Rosmorduc O,Wendum D,Corpechot C,Galy B,Sebbagh N,Raleigh J,Housset C,Poupon R.Hepatocellular hypoxiainduced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis.Am J Pathol 1999; 155:1065-1073
  • 7[6]Yoshiji H,Kuriyama S,Yoshii J,Ikenaka Y,Noguchi R,Hicklin DJ,Wu Y,Yanase K,Namisaki T,Yamazaki M,Tsujinoue H,Imazu H,Masaki T,Fukui H.Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.Gut 2003; 52:1347-1354
  • 8[7]Wang YQ,Ikeda K,Ikebe T,Hirakawa K,Sowa M,Nakatani K,Kawada N,Kaneda K.Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats.Hepatology 2000; 32:980-989
  • 9[8]Vogten JM,Drixler TA,te Velde EA,Schipper ME,van Vroonhoven TJ,Voest EE,Borel Rinkes IH.Angiostatin inhibits experimental liver fibrosis in mice.Int J Colorectal Dis 2004; 19:387-394
  • 10[9]Bornstein P.Thrombospondins as matricellular modulators of cell function.J Clin Invest 2001; 107:929-934

共引文献11

同被引文献41

  • 1王忠富,侯毅斌,李建生,卢斌贵,陈国硕,汤日杰.78例腮腺肿瘤的CT图像特点及诊断价值[J].医学信息(医学与计算机应用),2014,0(29):37-38. 被引量:1
  • 2霍钢,田加坤,唐文渊,郑履平,易勇.MMP-2及CD147在侵袭性垂体腺瘤中的表达及其相互关系的研究[J].中国神经精神疾病杂志,2005,31(3):168-171. 被引量:19
  • 3杨伟,曲元明,徐广明,韩韬.TSP1/TGFβ与垂体瘤血管生成及侵袭性的关系[J].中华神经外科杂志,2005,21(11):695-698. 被引量:6
  • 4Heaney A P, Fernando M, Melmed S. PPAR-gamma re?ceptor ligands: novel therapy for pituitary adenomas[J] .J Clin Invest, 2003,111 (9) : 1381-1388.
  • 5Pasche B. Role of transforming growth factor beta in cancer[J].J Cell Physiol, 2001,186(2):153-168.
  • 6Butz H, Lik6 I, Czirjdk S, et al. MicroRNA profile indi?cates downregu1ation of the TGF[3 pathway in sporadic non-functioning pituitary adenomas[J]. Pituitary, 2011, 14(2) :112-124.
  • 7Dallago C M, Barbosa-Coutinho L M, Ferreira N P, et al. Determination of cell proliferation using Mcm2 antigen and evaluation of apoptosis and TGF-beta1 expression in GH-secreting or clinically nonfunctioning pituitary adeno?masJ J]. Endocr Patho1, 2010, 21(1) :32-39.
  • 8Recouvreux M V, Guida M C, Rifkin DB, et al. Active and total transforming growth factor-Bl are differentially regulated by dopamine and estradiol in the pituitary[J] . Endocrinology, 2011, 152(7) :2722-2730.
  • 9Renner U, Lohrer P, Schaaf L, et al. Transforming growth factor-B stimulates vascular endothelial growth fac?tor production by folliculostellate pituitary cells[J]. En?docrinology, 2002, 143 (10) :3759- 3765.
  • 10Ruebel K H, Leontovich A A, Tanizaki Y, et al. Effects of TGFbetal on gene expression in the HP75 human pitui?tary tumor cell line identified by gene expression profiling [J]. Endocrine, 2008, 33 (1) :62-76.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部